During the past decade, Ohio State University CRS conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ohio State University CRS" #1 collaborator was "AIDS Clinical Trials Group" with 4 trials as a collaborator, "ViiV Healthcare" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Adult AIDS Clinical Trials Group" with 1 trials as a collaborator and "Dynavax Technologies Corporation" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Ohio State University CRS" are "HIV Infections" (17 trials), "Hepatitis B" (2 trials), "CMV" (1 trials), "Cardiovascular Diseases" (1 trials) and "Cytomegalovirus" (1 trials). Many other conditions were trialed in "Ohio State University CRS" in a lesser frequency.

Most popular intervention types in "Ohio State University CRS" are "Drug" (17 trials), "Biological" (6 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Raltegravir" (2 trials), "Standard of Care (SOC) Oral ART" (2 trials), "Antiretroviral treatment" (1 trials) and "Boceprevir (BOC)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ohio State University CRS" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ohio State University CRS". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Ohio State University CRS, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ohio State University CRS, 6 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".